Abstract
Multimodality imaging is not only the present but also the future of diagnostic imaging. PET/CT is a hybrid device, which has the capability to provide a combination of anatomical and functional imaging due to the high spatial resolution of CT and the molecular imaging of PET.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal V, Branstetter BF IV, Johnson JT (2008) Indications for PET/CT in the head and neck. Otolaryngol Clin N Am 41:23–49
Grosu AL, Weber WA (2010) PET for radiation treatment planning of brain tumors. Radiother Oncol 96:325–327
Funk GF (2012) Head and neck surgeon’s perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers, clinical challenges in otolaryngology. Arch Otoralyngol Head Neck Surg 138(8):748–751
Lauren VZ, Wiggins RH (2012) A head and neck radiologist’s perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers, clinical challenges in otolaryngology. Arch Otoralyngol Head Neck Surg 138(8):754–758
Ha PK, Hdeib A, Goldenberg D et al (2006) The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132(1):12–16
Rusthoven KE, Koshy M, Paulino AC et al (2004) The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 101(11):2641–2649
Ahn PH, Garg MH (2008) Positron emission tomography/computed tomography for target delineation in head and neck cancers. In: Seminars in nuclear medicine, Department of Radiation Oncology, pp 141–147
Souvatzoglou M, Grosu AL, Roper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla HJ, Wester HJ, Piert M (2007) Tumor hypoxia imaging with FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging 34:1566–1575
Kostakoglu L, Valk PE (2006) Assessment of treatment response by FDG-PET. Positron Emission Tomography. Springer, 405:387–389
Quon A, Fischbein NJ, Ross McDougal I, Le Q-T, Loo BW, Pinto H, Kaplan MJ (2007) Clinical role of F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 48:58S–67S
Buchbender C, Heusner TA, Lauestein TC, Bockisch A, Antoch G (2012) Oncologic PET/MRI, Part1: tumors of the brain, head and neck, chest, abdomen and pelvis. J Nucl Med 53:1–11
Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL, Kiess AP, Kang H, Subramaniam RM (2014) Head and neck PET/CT: therapy response interpretation criteria (hopkins criteria)-interreader reliability, accuracy, and survival outcomes. J Nucl Med 55:1411–1416
Sjovall J, Bitze’n U, Kjelle’n E et al (2015) Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 43:609–616
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Vlachou, F.J. (2018). PET-CT Findings in Head and Neck Cancer. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-68873-2_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68872-5
Online ISBN: 978-3-319-68873-2
eBook Packages: MedicineMedicine (R0)